Corporate Stock Transfer, Inc. v. AE Biofuels, Inc.

663 F. Supp. 2d 1056, 2009 U.S. Dist. LEXIS 99754, 2009 WL 3287547
CourtDistrict Court, D. Colorado
DecidedOctober 13, 2009
Docket1:09-mj-01013
StatusPublished
Cited by23 cases

This text of 663 F. Supp. 2d 1056 (Corporate Stock Transfer, Inc. v. AE Biofuels, Inc.) is published on Counsel Stack Legal Research, covering District Court, D. Colorado primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Corporate Stock Transfer, Inc. v. AE Biofuels, Inc., 663 F. Supp. 2d 1056, 2009 U.S. Dist. LEXIS 99754, 2009 WL 3287547 (D. Colo. 2009).

Opinion

ORDER

KATHLEEN M. TAFOYA, United States Magistrate Judge.

This matter is before the court on Surendra Kumar Ajjarapu’s and Sandhya Ajjarapu’s (“Ajjarapus”) “Motion for Leave to File Amended and Restated Complaint and to Join Party on Behalf of Counter-Claimants/Cross-Claimants” (“Motion”) [Doc. No. 37, filed September 5, 2009] and the brief in support [Doc. No. 38]. AE Biofuels, Inc. (“AE”) filed its “Opposition to Cross-Claimants’ Motion for Leave to File Amended and Restated Complaint” (“AE Response”) [Doc. No. 40] on September 11, 2009 and Corporate Stock Transfer, Inc. (“CST”) filed its “Opposition to Motion for Leave To File an Amended and Restated Complaint” (“CTS Response”) [Doc. No. 44] on September 25, 2009. The Ajjarapus filed a Reply to AE’s objection on September 25, 2009. [Doc. No. 45]. The Motion seeks leave to file an Amended Complaint which would re-align the parties in this interpleader case and to add claims and parties to the Ajjarapus former counter and cross claims.

Also considered is CST’s related “Motion for Entry of Show Cause Order to Discharge Plaintiff from Liability and Injunction” [Doc. No. 8, filed June 2, 2009].

Procedural History

At the time of the filing of the Complaint, Plaintiff CST asserted that as the stock transfer agent for AE, CST maintains stock records and processes requests to transfer, register and issue shares of AE stock. (Compl. [Doc. No. 1] ¶¶ 7, 8.) As stockholders of 8,100,000 shares of AE stock, the Ajjarapus dealt with CST in an attempt to receive their stock certificates in an unrestricted to facilitate sale. (Id. ¶ 12.) CST received instructions from the Ajjarapus concerning the removal of a restrictive legend on their stock shares in December 2008. (Id. ¶ 18.) CST received conflicting instructions from AE not to remove the legend. (Id. ¶ 22.) The Ajjarapus and AE disagreed, and apparently continue to disagree, about the interpretation of Securities and Exchange Commission (“SEC”) Rule 144 of the Securities Act of 1933 and its effect on the removal of the restrictive legend contained on the Ajjarapus stock and, consequently, on the Ajjarapus ability to re-sell the stock. 1 At the time of the filing of the Complaint, CST claimed that as a result of the conflicting legal interpretations provided by the Ajjarapus and AE as to whether the conditions of SEC Rule 144 had been satis *1060 fied, CST was unable to determine whether it had a legal duty to follow the instructions of AE, nominal issuer of the stock, or whether it should follow the instructions of the Ajjarapus, the stockholders. (Id. at ¶ 32.) Therefore CST impleaded the stock and requested it be reimbursed the costs and expenses of the litigation. (Id. at 38, 39.)

On July 1, 2009, the Ajjarapus filed, with their Answer to the Complaint, their Cross-claims and Counterclaims against AE and CST (“Cross and Counterclaims”). [Doc. No. 10.] The Ajjarapus brought claims against AE for breach of fiduciary duty, conversion, securities fraud in violation of § 10(b) of the Exchange Act and Rule 10b-5 (15 U.S.C. § 78j(B) and 17 C.F.R. § 240.10B-5), and sought damages and injunctive relief. (Id.) The Ajjarapus brought claims against CST for declaratory judgment concerning the application of SEC Rule 144 with respect to the AE stock owned by the Ajjarapus, claiming that CST “unlawfully failed in its duties as transfer agent of AE by failing to abide by the Shareholders’ lawful and fully 144 compliant requests, or alternatively, the Shareholders’ rights to resell their AE Stock pursuant to § 4(1) and § 4(2) of the Act and to re-issue their AE Stock without restrictive legend,.... ” (Id. at 18.)

On July 28, 2009, AE filed a Motion to Dismiss pursuant to Fed.R.Civ.P. 12(b)(6) claiming that: (1) the Ajjarapus’ common law claims of breach of fiduciary duty and conversion are preempted by the UCC;(2) in connection with their securities fraud claim, the Ajjarapus’ failed to allege that AE made untrue or misleading statements of material fact, that the statements were made in connection with the purchase or sale of securities, that AE acted with the intent to defraud or with recklessness, and that the Ajjarapus relied on the misleading statements; and (3) the Ajjarapus failed to plead the necessary elements to obtain injunctive relief. [Doc. No. 26.]

At the Scheduling Conference held by this court on July 30, 2009, the parties advised the court that CTS would be removing the restrictive legend on the stock certificates at issue and that the Ajjarapus would likely be filing an Amended Complaint to re-align the parties and set forth the appropriate damage claims. (Minutes of Scheduling Conference, July 30, 2009 [Doc. No. 28].) All parties appeared to be in accord with this procedure. Thereafter, the Ajjarapus filed their Amended Complaint on August 31, 2009. [Doc. No. 35.] After receiving notice that a court order was required to file the proposed Amended Complaint, this motion, now opposed, was filed by the Ajjarapus on September 5, 2009.

AE objects to the filing of the proposed Amended Complaint on the basis that it attempts to add as a new defendant, Crone Rozynko, LLP (“Crone”), the California law firm which represented AE during much of the relevant time period and with whom AE’s corporate counsel was formerly associated, asserting that this court lacks personal jurisdiction over Crone. Additionally, AE objects to the proposed Amended Complaint on the basis that the Ajjarapus re-allege tort claims AE believes are barred by law, that the proposed Amended Complaint seeks to join CTS in its Rule 10b-5 securities fraud claim which AE claims is facially deficient, and that the proposed Amended Complaint fails to allege fraud with the required specificity. AE also claims that the proposed Amended Complaint, as constituted, is brought in bad faith to “ ‘leverage’ AE Biofuels and CST by suing lawyers without jurisdiction and making allegations which lack foundation in fact and fail to state a claim.” [AE Resp. at ¶ 1.] CTS joined AE’s Response and added as additional grounds for denial *1061 of the proposed Amended Complaint that the Amended Complaint is futile because it does not allege the requisite scienter on the part of CTS to state a securities fraud claim and that such a claim against CTS has not been stated with adequate particularity pursuant to Fed.R.Civ.P. 9(b).

Legal Standards

Pursuant to Fed. R. Civ. P 15(a), the court is to freely allow amendment of the pleadings “when justice so requires.” The grant or denial of an opportunity to amend is within the discretion of the court, but “outright refusal to grant the leave without any justifying reason appearing for the denial is not an exercise of discretion; it is merely abuse of that discretion and inconsistent with the spirit of the Federal Rules.” Foman v. Davis,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
663 F. Supp. 2d 1056, 2009 U.S. Dist. LEXIS 99754, 2009 WL 3287547, Counsel Stack Legal Research, https://law.counselstack.com/opinion/corporate-stock-transfer-inc-v-ae-biofuels-inc-cod-2009.